Literature DB >> 26548507

Risk factors for late recurrent candidaemia. A retrospective matched case-control study.

P Muñoz1, A Vena2, M Valerio3, A Álvarez-Uría3, J Guinea3, P Escribano3, E Bouza4.   

Abstract

Incidence, risk factors and clinical significance of late recurrent (LR) candidaemia (>1 month between episodes) remains unclear. The 1219 episodes of candidaemia detected from January 1985 to December 2014 were reviewed. We selected all cases with more than one episode separated by at least 30 days after clinical resolution in the interim (cases) and compared each of them with two controls (patients with single episodes of candidaemia). Clinical strains were genotyped to differentiate relapses from re-infection. Eighteen patients (1.48%) had 36 episodes of LR candidaemia (median 4 months). Independent risk factors for recurrence in the multivariate analysis were: underlying gastrointestinal disease (OR 67.16; 95% CI 5.23-861.71; p 0.001) and fungaemia due to Candida parapsilosis (OR 9.10; 95% 1.33-62.00; p 0.02). All episodes of LR candidaemia diagnosed during the first 3 months were due to an intravascular source of infection, whereas in those occurring after 3 months the main source of the disease was the abdomen, followed by endocarditis, and urinary tract. Molecular typing showed that 42.9% of LR candidaemias were relapses and 57.1% were re-infections. Neither time of recurrence nor clinical origin could predict type of recurrence. LR candidaemia is a relatively rare event that is more frequent in patients who have an initial episode of candidaemia due to C. parapsilosis or an underlying gastrointestinal disease. Episodes of LR candidaemia that occur within the first 3 months should prompt an attempt to exclude an intravascular source of infection, whereas those occurring later point to an intra-abdominal origin.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Candida endocarditis; candidaemia; candidiasis; invasive disease; recurrent infection

Mesh:

Substances:

Year:  2015        PMID: 26548507     DOI: 10.1016/j.cmi.2015.10.023

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

Review 1.  Abdominal Sepsis.

Authors:  Jan J De Waele
Journal:  Curr Infect Dis Rep       Date:  2016-08       Impact factor: 3.725

2.  Candida parapsilosis endocarditis. Report of cases and review of the literature.

Authors:  Petros Ioannou; Maria Volosyraki; Vasiliki Mavrikaki; Ioanna Papakitsou; Anna Mathioudaki; George Samonis; Diamantis P Kofteridis
Journal:  Germs       Date:  2020-09-01

3.  Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant Organisms.

Authors:  Gil Marcus; Samuel Levy; Ghaleb Salhab; Bethlehem Mengesha; Oran Tzuman; Shira Shur; Erica Burke; Rebecca Cruz Mayeda; Lior Cochavi; Idan Perluk; Ronit Zaidenstein; Tsilia Lazarovitch; Mor Dadon; Dror Marchaim
Journal:  Open Forum Infect Dis       Date:  2016-12-20       Impact factor: 3.835

4.  Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Lan-Yan Yang; Yu-Bin Pan; Mei-Yin Lai; Shih-Ming Chu; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Jang-Jih Lu
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

5.  Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey.

Authors:  Kai-Manuel Adam; Michael Osthoff; Frédéric Lamoth; Anna Conen; Véronique Erard; Katia Boggian; Peter W Schreiber; Stefan Zimmerli; Pierre-Yves Bochud; Dionysios Neofytos; Mapi Fleury; Hans Fankhauser; Daniel Goldenberger; Konrad Mühlethaler; Arnaud Riat; Reinhard Zbinden; Andreas Kronenberg; Chantal Quiblier; Oscar Marchetti; Nina Khanna
Journal:  Open Forum Infect Dis       Date:  2021-09-17       Impact factor: 3.835

6.  Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors.

Authors:  Federica Briano; Laura Magnasco; Daniele Roberto Giacobbe; Matteo Bassetti; Chiara Sepulcri; Silvia Dettori; Chiara Dentone; Malgorzata Mikulska; Lorenzo Ball; Antonio Vena; Chiara Robba; Nicolò Patroniti; Iole Brunetti; Angelo Gratarola; Raffaele D'Angelo; Vincenzo Di Pilato; Erika Coppo; Anna Marchese; Paolo Pelosi
Journal:  Infect Dis Ther       Date:  2022-04-11

7.  Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Shih-Ming Chu; Pey-Jium Chang; Mei-Yin Lai; I-Hsyuan Wu; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Jang-Jih Lu
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

8.  Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates.

Authors:  Jen-Fu Hsu; Mei-Yin Lai; Chiang-Wen Lee; Shih-Ming Chu; I-Hsyuan Wu; Hsuan-Rong Huang; I-Ta Lee; Ming-Chou Chiang; Ren-Huei Fu; Ming-Horng Tsai
Journal:  BMC Infect Dis       Date:  2018-04-24       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.